Care and treatment subtopic
| |
Articles
1-300 out of 500 article(s) next
| Title |
Author |
Type |
Date |
Words |
| Nature Neuroscience Study Shows Unique Scientific Support for Potential New Myelin Repair Treatment for Multiple Sclerosis. |
|
|
May 20, 2012 |
587 |
| Serono Symposia International Foundation Gathers Experts in Valencia for the 2012 CME Annual Meeting in Multiple Sclerosis. |
|
|
May 18, 2012 |
508 |
| While U.S. Patients Report High Levels of Satisfaction with Current DMAs, Switching Interest is Highest among Patients for Sanofi / Genzyme's Teriflunomide and Biogen Idec's BG-12, According to a Recent BioTrends Report. |
|
|
May 17, 2012 |
882 |
| The world can be yours: MS can't stop the savvy traveler: MS don't have to keep people home. Thanks to technology, accessibility laws and a dash of ingenuity, people with MS are increasingly able to travel where ever there imagine. |
Nauen, Elinor |
Cover story |
May 17, 2012 |
4377 |
| Taking a fresh look at the immune attack in MS. |
Bernstein, Sara |
|
May 17, 2012 |
1361 |
| In the pipeline for MS: Vitamin D supplementation. |
|
|
May 17, 2012 |
463 |
| Priorities for funding MS research. |
Coetzee, Timothy |
|
May 17, 2012 |
421 |
| Study focuses on Hispanics/Latinos who have MS. |
|
Brief article |
May 17, 2012 |
116 |
| Cannabis may help reduce common symptoms of multiple sclerosis. |
|
Clinical report |
May 15, 2012 |
432 |
| New AVONEX[R] Dosing Innovations for People with Multiple Sclerosis Now Available in US. |
|
|
May 14, 2012 |
1427 |
| Vascular Expert Supports FDA Warning about Experimental Therapy for MS Patients. |
|
|
May 11, 2012 |
266 |
| Significant Improvement in Disability Scores Observed in Multiple Sclerosis Patients Who Received LemtradaTM* (Alemtuzumab) Compared With Rebif[R] in Phase III Trial. |
|
|
Apr 24, 2012 |
2977 |
| Opexa to Hold Preliminary Investigator's Meeting for MS Trial at American Academy of Neurology Annual Meeting. |
|
|
Apr 19, 2012 |
1123 |
| Is marijuana medicinal? |
Abrams, Donald I.; Trafton, Jodie |
|
Apr 15, 2012 |
1506 |
| Symptom clusters in women with relapsing-remitting multiple sclerosis. |
Newland, Pamela K.; Fearing, Arleen; Riley, Marguerite; Neath, Andrew |
|
Apr 1, 2012 |
3773 |
| Vitamin D and multiple sclerosis. |
Gaby, Alan R. |
Editorial |
Apr 1, 2012 |
1131 |
| Angioplasty may help ease symptoms of multiple sclerosis. |
|
|
Mar 26, 2012 |
658 |
| 3,000 patients to get new MS drug on NHS; Move comes after North East drug trial. |
|
|
Mar 17, 2012 |
627 |
| MS pill to be made available to NHS patients. |
|
|
Mar 16, 2012 |
216 |
| The Beals family: on the frontlines fueling MS research. |
de Klerk, Erica |
|
Mar 3, 2012 |
424 |
| Federal research program takes aim at MS: the innovative research projects that focus on MS seek to improve assessment of and develop novel treatments for veterans and civilians living with MS. |
Smedman, Lorna |
|
Mar 3, 2012 |
965 |
| Writing the story behind every face of MS. |
Coetzee, Timothy |
|
Mar 3, 2012 |
489 |
| Passionate determination: all of us in the MS Movement are connected by the passion to create meaningful change in the lives of people affected by MS. We are activists. |
Zagieboylo, Cyndi |
|
Mar 3, 2012 |
482 |
| Outcome moderators of a fatigue management program for people with multiple sclerosis. |
Finlayson, Marcia; Preissner, Katharine; Cho, Chi |
Report |
Mar 1, 2012 |
6829 |
| Experience of glatiramer acetate in the treatment of relapsing-remitting multiple sclerosis patients/Relapsing-remitting multipl skleroz hastalarinda glatiramer asetat deneyimi. |
Taskapilioglu, Ozlem; Turan, Asli Bahar; Albas, Murat; Turan, Omer Faruk |
Report |
Mar 1, 2012 |
2591 |
| In 2015, Biogen Idec's BG-12 Will Earn Decision Resources' Proprietary Clinical Gold Standard Status for the Treatment of Relapsing-Remitting Multiple Sclerosis. |
|
|
Feb 29, 2012 |
796 |
| Biogen Idec Submits Application to FDA for Approval of Oral BG-12 to Treat Multiple Sclerosis. |
|
|
Feb 28, 2012 |
706 |
| A walk MS family goes national: far-flung friends and relatives can get closer through Walk MS. Here's how one family did it. |
Wadsley, Patricia |
Cover story |
Feb 25, 2012 |
643 |
| Aging well with MS: some studies suggest that lifestyle choices may have a greater impact than genetics on how well we age. How well we live, and therefore age, may be to a great extent in our control. |
Watson, Stephanie |
|
Feb 25, 2012 |
3091 |
| Menopause and MS. |
Dale, Alison |
|
Feb 25, 2012 |
798 |
| Highlight: the nerve dance: numbness and tingling: MS-related numbness and tingling can be a serious pain. People with MS and MS specialists share ways to address-and cope with--these common MS symptoms. |
Nauen, Elinor |
|
Feb 25, 2012 |
1586 |
| A physician's bladder control problem. |
|
Brief article |
Feb 1, 2012 |
324 |
| Merck Serono Receives European Approval to Expand Use of Rebif in Patients with Early Multiple Sclerosis. |
|
|
Jan 25, 2012 |
1392 |
| Advanced Magnetic Resonance Imaging Technology Suggests Axonal Repair in Multiple Sclerosis Patients Treated with COPAXONE[R]. |
|
|
Jan 3, 2012 |
1296 |
| Cash shortage forces health board to limit MS treatment; NICE-APPROVED THERAPY DENIED TO NEW PATIENTS. |
|
|
Dec 5, 2011 |
781 |
| Pioneering MS therapy on hold. |
|
|
Dec 5, 2011 |
597 |
| Self-management in neurological disorders: systematic review of the literature and potential interventions in multiple sclerosis care. |
Rae-Grant, Alex D.; Turner, Aaron P.; Sloan, Alicia; Miller, Deborah; Hunziker, James; Haselkorn, Jo |
Report |
Dec 1, 2011 |
7445 |
| Increasing physical activity in multiple sclerosis: replicating Internet intervention effects using objective and self-report outcomes. |
Dlugonski, Deirdre; Motl, Robert W.; McAuley, Edward |
Report |
Dec 1, 2011 |
4695 |
| Nursing management of the patient with multiple sclerosis. |
Thompson, Hilaire |
|
Dec 1, 2011 |
680 |
| Single with MS. |
Duff, Donna; Carroll, Marion Leeds |
Letter to the editor |
Nov 29, 2011 |
202 |
| The psychological effects of exercise: does exercise have a proven positive impact on mood or emotions in people with MS? The author has personal and professional reasons to examine the evidence. |
Anthony, William A. |
Report |
Nov 29, 2011 |
921 |
| Getting a handle on MS pain: like almost everything else MS, MS pain has many forms and many causes. It warrants exploring many different therapies. |
Adelson, Rachel |
Report |
Nov 29, 2011 |
3460 |
| Work incentives that can work for people with MS. |
Russon, Helen; Pike, Bob |
Report |
Nov 29, 2011 |
1048 |
| In the pipeline for MS: lipoic acid. |
|
|
Nov 29, 2011 |
458 |
| Seventy-Four Percent of Surveyed U.S. Neurologists Indicate They Will Prescribe Biogen Idec's BG-12 for the Treatment of Relapsing-Remitting Multiple Sclerosis. |
|
|
Nov 28, 2011 |
781 |
| Avanir Pharmaceuticals Announces Enrollment of First Patient in PRIME Study of AVP-923 in Central Neuropathic Pain in Multiple Sclerosis. |
|
|
Nov 3, 2011 |
1435 |
| While Copaxone and Interferon-Betas Continue to Dominate Treatment in MS, Tysabri Shows Modest Increase in First-Line Use. |
|
|
Nov 2, 2011 |
553 |
| Alemtuzumab (Lemtrada[TM]*) Significantly Reduces Relapses in Multiple Sclerosis vs Interferon Beta-1a in a Phase III Study. |
|
|
Oct 22, 2011 |
2221 |
| Oral Therapy Teriflunomide (Aubagio(TM)(*)) Significantly Reduces Relapses Leading to Hospitalization of Patients with Multiple Sclerosis. |
|
|
Oct 20, 2011 |
1810 |
| Significant Reduced Loss of Brain Volume in Multiple Sclerosis Patients Treated with COPAXONE[R]. |
|
|
Oct 11, 2011 |
1339 |
| Immune-related genetic loci linked to multiple sclerosis. |
Splete, Heidi |
Report |
Oct 1, 2011 |
867 |
| Elliptical exercise improves fatigue ratings and quality of life in patients with multiple sclerosis. |
Huisinga, Jessie M.; Filipi, Mary L.; Stergiou, Nicholas |
Report |
Sep 23, 2011 |
5958 |
| Some cures that weren't. |
Bowling, Allen C. |
|
Sep 22, 2011 |
1198 |
| What is palliative care? |
Shaw, Gina |
|
Sep 13, 2011 |
1039 |
| Dystel Prize winner Dr. Brian Weinshenker on getting MS right. |
Bernstein, Sara |
|
Sep 13, 2011 |
1315 |
| Taking a lesson from failure. |
Coetzee, Timothy |
|
Sep 13, 2011 |
585 |
| A quote for the road ... |
Nelson, Joyce |
Column |
Sep 13, 2011 |
420 |
| The role of drugs or surgery: what's the doctor got to keep people moving should mobility decline? |
Wojcik, Emily |
|
Sep 13, 2011 |
878 |
| Medical Marijuana Inc. Marijuana Extract Cannabidiol (CBD) Shows Therapeutic Benefit For Multiple Sclerosis (MS). |
|
|
Sep 13, 2011 |
757 |
| Dr. Mark Freedman to Join Opexa's Scientific Advisory Board. |
|
|
Sep 12, 2011 |
1228 |
| Inhibikase Therapeutics Receives FDA Clearance for Phase II Trial of IkT-001 to Treat JC Virus Infection, the Cause of Progressive Multifocal Leukoencephalopathy (PML) in Multiple Sclerosis Patients. |
|
|
Aug 16, 2011 |
868 |
| Allergan's BOTOX[R] Receives A Positive Opinion in Fourteen European Countries for Urinary Incontinence in Patients with MS or Spinal Cord Injury. |
|
|
Aug 8, 2011 |
2573 |
| New Mobile App for Patients with Multiple Sclerosis and Diabetes. |
|
|
Aug 4, 2011 |
348 |
| New study raises hope in MS fight; trial. |
|
|
Jul 30, 2011 |
129 |
| Decreased central fatigue in multiple sclerosis patients after 8 weeks of surface functional electrical stimulation. |
Chang, Ya-Ju; Hsu, Miao-Ju; Chen, Shin-Man; Lin, Cheng-Hsiang; Wong, Alice M.K. |
Report |
Jul 26, 2011 |
6263 |
| Daval International Announces Completion of Phase II Trial for the Treatment of Bladder Dysfunction With AIMSPRO in Secondary Progressive Multiple Sclerosis. |
|
Clinical report |
Jul 20, 2011 |
720 |
| Teva's Copaxone Maintains a Dominant Presence in the MS Treatment Algorithm among Both Newly Diagnosed and Recently Treated Patients. |
|
|
Jul 13, 2011 |
533 |
| Sanofi Reports Positive Top-Line Results from First Phase 3 Study of Alemtuzumab (Lemtrada[TM] (*)) in Multiple Sclerosis. |
|
|
Jul 11, 2011 |
1870 |
| American Access Care Hosts Special Education Day for MS Patients and Caregivers. |
|
|
Jul 6, 2011 |
361 |
| Merck Serono Submits Application for Extension of Indication for Rebif(R) in Europe. |
|
|
Jun 29, 2011 |
1367 |
| SIR Foundation Sets Research Priorities for Minimally Invasive Treatments for MS Patients. |
|
|
Jun 16, 2011 |
1080 |
| Accentia Biopharmaceuticals Announces Financing to Advance Revimmune[TM] to Treat Autoimmune Disease including Multiple Sclerosis. |
|
|
Jun 14, 2011 |
1114 |
| Group therapy helps Multiple Sclerosis patients cope with depression. |
|
|
Jun 14, 2011 |
156 |
| Effect of robot-assisted versus conventional body-weight-supported treadmill training on quality of life for people with multiple sclerosis. |
Wier, Lauren M.; Hatcher, Mary S.; Triche, Elizabeth W.; Lo, Albert C. |
Report |
Jun 11, 2011 |
6618 |
| Teva Announces Patient Characteristic Data from the Therapy Optimization in Multiple Sclerosis (TOP MS) Study at Consortium of Multiple Sclerosis Centers Meeting. |
|
Clinical report |
Jun 5, 2011 |
1248 |
| New data may tweak Natalizumab's use in MS. |
Boschert, Sherry |
|
Jun 1, 2011 |
1361 |
| Biogen Idec Celebrates World MS Day. |
|
|
May 25, 2011 |
2094 |
| Unlocking the puzzle of progression: the puzzle is big and full of missing pieces. Today, teams of researchers around the planet are combining their efforts to change that. |
O'Dell, Holly |
Cover story |
May 24, 2011 |
2785 |
| Progression continues: the author has lived with worsening MS for nearly 25 years. |
Cohen, Joyce Render |
Viewpoint essay |
May 24, 2011 |
960 |
| Progression is unpredictable: the author has lived with MS for 22 years. His experience illustrates how different MS can be from person to person. |
Luebeck, Jack |
Viewpoint essay |
May 24, 2011 |
468 |
| How we grew: team Droopy and Bike MS. |
Durand, Marcella |
|
May 24, 2011 |
571 |
| Parenting and MS: what Momentum readers think: having children is, at heart, about the future. But having MS is about the future, too. |
Durand, Marcella |
|
May 24, 2011 |
1020 |
| The dating game: MS brings some special considerations when it comes to dating, but that doesn't mean MS defines you. |
Wojcik, Emily |
|
May 24, 2011 |
1097 |
| Millie and me: progressive MS stole many things from the author. Her dog Millie helps her get some of them back. |
Mathias, Cissie |
Viewpoint essay |
May 24, 2011 |
705 |
| How are you? Why quality of life matters in MS research and care. |
Bernstein, Sara |
Disease/Disorder overview |
May 24, 2011 |
1518 |
| The deep science of cannabinoids for MS. |
|
|
May 24, 2011 |
577 |
| MS = is on my mind, all year long. |
Nelson, Joyce |
Essay |
May 24, 2011 |
411 |
| Biogen Idec Launches Women in MS Educational Initiative. |
|
|
May 24, 2011 |
1004 |
| New nanoscopic imaging could help detect, treat multiple sclerosis. |
|
|
May 24, 2011 |
261 |
| Biogen Idec Receives Approval for FAMPYRA in Australia to Improve Walking Ability in Adult Patients with MS. |
|
|
May 16, 2011 |
1119 |
| T-cell therapy may do more harm than good for Multiple Sclerosis patients. |
|
|
May 8, 2011 |
283 |
| Susman Godfrey's Cycling Team "Swift Justice" Raises $100,000 to Fight Multiple Sclerosis. |
|
|
Apr 20, 2011 |
732 |
| New Study Demonstrated Significant Reduction in Annualized Relapse Rate and Halting of Disability Progression in MS Patients Switching To Copaxone[R]. |
|
|
Apr 14, 2011 |
1494 |
| Seventy-Eight Percent of National Health Plans Will Reimburse for Emerging Oral Therapies for Multiple Sclerosis. |
|
|
Apr 14, 2011 |
568 |
| Five-year Alemtuzumab Phase 2 Data Shows Large Percentage of MS Patients Remain Free of Clinically-Active Disease. |
|
|
Apr 14, 2011 |
1714 |
| Novartis Therapy Gilenya(TM) Reduced the Risk of MS Disability Progression Regardless of Treatment History or Disease Severity, New Analysis Shows. |
|
|
Apr 11, 2011 |
2268 |
| Access to MS treatment under fire. |
|
|
Mar 28, 2011 |
182 |
| Interventional Radiologists Advance MS Research: Vein-Opening Treatment Safe. |
|
|
Mar 28, 2011 |
1432 |
| Stem cells may help treat aggressive multiple sclerosis. |
|
|
Mar 22, 2011 |
322 |
| "Who is the extraordinary one?". |
Muntzel, Jacob |
Essay |
Mar 17, 2011 |
466 |
| "What can I do to help?" Three generations of Scriveners have asked this question! |
de Klerk, Erica |
|
Mar 17, 2011 |
406 |
| Researchers search for footprints--or "biomarkers"--to help track the course of MS. |
Coetzee, Timothy |
|
Mar 17, 2011 |
1205 |
| A new era: new drugs, new options, new risks: there may soon be a doubling of treatment options for MS. Already known to be unpredictable and different from person to person, MS will demand even more thoughtful individual decisions about the best road to take. |
King, Martha |
Cover story |
Mar 15, 2011 |
3450 |
| Not your granddad's rehab: researchers are working on new ways to improve balance, dexterity and mobility in MS. |
Paturel, Amy |
|
Mar 15, 2011 |
1062 |
| Unstoppable! |
Nelson, Joyce |
Viewpoint essay |
Mar 15, 2011 |
374 |
| Symptom management highlight: bowel issues. |
Adelson, Rachel |
|
Mar 15, 2011 |
1363 |
| Placebos and nocebos--techniques to optimize MS management? |
Bowling, Allen C. |
|
Mar 15, 2011 |
1193 |
| Sativex(R) Launched in Spain to Treat Spasticity in Multiple Sclerosis (MS). |
|
|
Mar 14, 2011 |
1315 |
| Losing out on MS treatment; Patient has been waiting since August. |
|
|
Mar 2, 2011 |
432 |
| Assemblymember Fiona Ma, National Multiple Sclerosis Society and Alliance for Plasma Therapies Announce Landmark Legislation to Protect California Patients from Discriminatory Price Increases on Vital Medication. |
|
|
Feb 10, 2011 |
846 |
| Expert Panel Publishes Findings on Benefits of Underutilized Intrathecal Baclofen Therapy for Severe Spasticity in Multiple Sclerosis Patients. |
|
|
Feb 3, 2011 |
854 |
| Emerging oral therapies for multiple sclerosis. |
Miller, Colleen E.; Umhauer, Margaret A. |
Report |
Feb 1, 2011 |
7701 |
| Merck Serono Announces Outcome of Its Request for Reexamination of CHMP Opinion for Cladribine Tablets in MS. |
|
|
Jan 21, 2011 |
1367 |
| Biogen Idec Receives Negative Opinion from the CHMP on FAMPYRA. |
|
|
Jan 21, 2011 |
1160 |
| Controversial MS Treatment Lessens Fatigue, Research at ISET 2011 Shows. |
|
|
Jan 17, 2011 |
409 |
| Falls requiring medical attention among veterans with multiple sclerosis: a cohort study. |
Cameron, Michelle H.; Poel, Amy J.; Haselkorn, Jodie K.; Linke, Alex; Bourdette, Dennis |
Report |
Jan 1, 2011 |
5608 |
| The Gillispie whirlwind. |
King, Martha |
Interview |
Dec 22, 2010 |
472 |
| Baby time? MS and pregnancy. |
Watson, Stephanie |
Cover story |
Dec 22, 2010 |
2183 |
| The no kids option. |
Watson, Stephanie |
Brief article |
Dec 22, 2010 |
242 |
| The adoption options. |
Watson, Stephanie |
|
Dec 22, 2010 |
677 |
| And baby makes ... |
Watson, Stephanie |
|
Dec 22, 2010 |
1256 |
| A new research funding model ... and how people with MS are making it happen. |
Hasson, Judi |
|
Dec 22, 2010 |
833 |
| Family. |
King, Martha |
Editorial |
Dec 22, 2010 |
344 |
| Strength training: is it safe? Does it work? Can I do it? |
Bobryk, Patty |
|
Dec 22, 2010 |
744 |
| "Oh, dude--it's my MS". |
Wadsley, Patricia |
|
Dec 22, 2010 |
894 |
| The wheelchair: what they think; what you think. |
Wadsley, Patricia |
|
Dec 22, 2010 |
865 |
| European Neurologists Expect Significant Increases in the Use of Both Tysabri and Extavia in Their Multiple Sclerosis Patients the Next Six Months, According to a Recent Report From BioTrends. |
|
|
Dec 21, 2010 |
877 |
| Teva Announces Successful Results of Phase III Study with Oral Laquinimod for Multiple Sclerosis. |
|
Clinical report |
Dec 9, 2010 |
1703 |
| Quality of life in spite of an unpredictable future: the next of kin of patients with multiple sclerosis. |
Liedstrom, Elisabeth; Isaksson, Ann-Kristin; Ahlstrom, Gerd |
Report |
Dec 1, 2010 |
8356 |
| Recent developments in the early diagnosis and management of multiple sclerosis. |
Ross, Amy Perrin; Thrower, Ben W. |
Report |
Dec 1, 2010 |
8621 |
| Impact of earthquake on multiple sclerosis attacks/Depremin multipl skleroz ataklarina etkisi. |
Tuzun, Erdem; Polat, Aslihan; Akman-Demir, Gulsen; Kurtuncu, Murat; Mutlu, Melike; Aksay, Bahar; Bil |
Report |
Dec 1, 2010 |
2829 |
| Relation of serum uric acid level with cognitive functions and number of plaques in patients with relapsing-remitting multiple sclerosis/Relapsing-remitting multipl skleroz hastalarinda serum urik asit duzeyinin kognitif fonksiyonlar ve plak sayisi ile iliskisi. |
Yoldas, Tahir Kurtulus; Keklikoglu, Hava Donmez; Zengin, Ozkan; Solak, Elif Banu; Keskin, Selda |
Report |
Dec 1, 2010 |
3404 |
| Merck Serono Announces Extension of FDA Priority Review Period for Cladribine Tablets for the Treatment of Relapsing Forms of Multiple Sclerosis. |
|
|
Nov 26, 2010 |
929 |
| EMD Serono Announces Extension of FDA Priority Review Period for Cladribine Tablets for the Treatment of Relapsing Forms of Multiple Sclerosis. |
|
|
Nov 26, 2010 |
971 |
| Early treatment slowed progression of MS. |
Worcester, Sharon |
Clinical report |
Nov 15, 2010 |
565 |
| Incurable MS disease on rise in Pakistan. |
|
|
Nov 14, 2010 |
686 |
| ChartTrends: Multiple Sclerosis Report Reveals the Latest Approach to the Treatment and Management of MS. |
|
Disease/Disorder overview |
Nov 2, 2010 |
628 |
| Using geographic information system tools to improve access to MS specialty care in Veterans Health Administration. |
Culpepper, William J., II; Cowper-Ripley, Diane; Litt, Eric R.; McDowell, Tzu-Yun; Hoffman, Paul M. |
|
Nov 1, 2010 |
4537 |
| Finding quality of life despite MS: harnessing resilience. |
Vitali, S.A. |
Report |
Nov 1, 2010 |
3565 |
| Cutaneous side-effects of immunomodulators in MS. |
Lebrun, C.; Bertagna, M.; Cohen, M. |
Clinical report |
Nov 1, 2010 |
3656 |
| Multiple Sclerosis: The Big Questions--the MS Forum Workshop. |
Goodin, D.S. |
Conference notes |
Nov 1, 2010 |
4412 |
| Choosing outcome measures that reflect what is important to the patient: a case study of Clinical Pilates in a woman with multiple sclerosis. |
Hay-Smith, Jean; Standring, Debbie |
Case study |
Nov 1, 2010 |
5187 |
| Sanofi-aventis Initiates Phase III Study with Teriflunomide as Adjunct Therapy with Interferon Beta to Further Explore Clinical Benefits in Multiple Sclerosis. |
|
|
Oct 26, 2010 |
1378 |
| Early Initiation of Treatment with Copaxone[R] Provides Greater Effects in Delaying Conversion to Clinically Definite MS. |
|
|
Oct 16, 2010 |
1595 |
| Teriflunomide Successfully Reduces Relapses and is Well Tolerated in Multiple Sclerosis Patients. |
|
|
Oct 15, 2010 |
1618 |
| Teriflunomide Successfully Reduces Relapses and is Well Tolerated in Multiple Sclerosis Patients. |
|
|
Oct 15, 2010 |
1624 |
| Survey Highlights Gap Between Patient and Healthcare Professional Perceptions of Mobility Loss Due to Multiple Sclerosis. |
|
|
Oct 14, 2010 |
1058 |
| Relapsing-Remitting Multiple Sclerosis Patients Show Interest in New Oral Therapies, According to Study by GfK HealthCare. |
|
|
Oct 14, 2010 |
648 |
| Genzyme's Alemtuzumab Shows Sustained Reduction in Relapses and Disability in Five-Year Review of MS Patients from Phase 2 Trial. |
|
|
Oct 14, 2010 |
1718 |
| Merck Serono Notified EMA of its Intention to Appeal CHMP Opinion on Cladribine Tablets in MS. |
|
|
Oct 11, 2010 |
966 |
| Innate Therapeutics Initiates Phase 2 Testing of MIS416 in Patients With Progressive Multiple Sclerosis. |
|
Clinical report |
Oct 11, 2010 |
666 |
| Quality of life in patients with multiple sclerosis in turkey: relationship to depression and fatigue. |
Tanriverdi, Derya; Okanli, Ayse; Sezgin, Serap; Ekinci, Mine |
Report |
Oct 1, 2010 |
4842 |
| Introduction: adherence to disease-modifying therapies--key to optimizing outcomes in relapsing multiple sclerosis. |
Caon, Christina; Saunders, Carol; Smrtka, Jennifer; Davis, Karolyn; Davis, Alan; Kay, Jonathan M.; B |
Report |
Oct 1, 2010 |
2829 |
| Injectable disease-modifying therapy for relapsing-remitting multiple sclerosis: a review of adherence data. |
Caon, Christina; Saunders, Carol; Smrtka, Jennifer; Baxter, Nancy; Shoemaker, Jennifer |
Report |
Oct 1, 2010 |
3719 |
| Enhancing adherence through education. |
Smrtka, Jennifer; Caon, Christina; Saunders, Carol; Becker, Brenda L.; Baxter, Nancy |
Report |
Oct 1, 2010 |
8094 |
| 'Pointless' MS treatment doctor struck off. |
|
|
Sep 30, 2010 |
452 |
| 'Pointless' MS treatment doctor struck off. |
|
|
Sep 29, 2010 |
452 |
| Safe travels through the online world. |
Metcalf, Eric |
|
Sep 22, 2010 |
3650 |
| Comparing treatments. |
|
|
Sep 22, 2010 |
435 |
| We Keep Moving. |
|
|
Sep 22, 2010 |
421 |
| Inside a low-vision clinic. |
Cohen, Joyce Render; Katz, Evelyn Render |
|
Sep 22, 2010 |
654 |
| Mobility at your feet. |
Wojcik, Emily |
|
Sep 22, 2010 |
974 |
| MS experts--and experts-in-training--meet in Texas. |
|
Brief article |
Sep 22, 2010 |
159 |
| Health care reform: what happens now? Health Care Reform Implementation Team. |
|
|
Sep 22, 2010 |
1317 |
| Pop life. |
Benni-Weis, Marissa |
Viewpoint essay |
Sep 22, 2010 |
550 |
| The spasticity story. |
Nauen, Elinor |
|
Sep 22, 2010 |
1831 |
| The Funny Page: life lessons from Merv, Mike and Johnny. |
Ankerman, Doug |
Viewpoint essay |
Sep 22, 2010 |
513 |
| The forgotten man: men as caregivers. |
Watson, Stephanie |
|
Sep 22, 2010 |
1058 |
| Her father's footsteps. |
Durand, Marcella |
|
Sep 22, 2010 |
561 |
| Why we need more physician-scientists in MS and what stands in the way. |
Rudick, Richard |
|
Sep 22, 2010 |
909 |
| Illness onset as status passage for people with multiple sclerosis (MS). |
Vickers, Margaret H. |
Report |
Sep 22, 2010 |
8979 |
| Merck Serono's Cladribine Tablets for MS Approved in Australia. |
|
|
Sep 3, 2010 |
972 |
| Integrated multiple sclerosis care: new approaches and paradigm shifts. |
Wallin, Mitchell T. |
Guest editorial |
Sep 1, 2010 |
3171 |
| Five-year retrospective study of inpatient occupational therapy outcomes for patients with multiple sclerosis. |
Maitra, Kinsuk; Hall, Carole; Kalish, Terri; Anderson, Marita; Dugan, Erin; Rehak, Justine; Rodrigue |
Report |
Sep 1, 2010 |
3923 |
| Teriflunomide Significantly Reduced Annualized Relapse Rate and was Well Tolerated in MS Patients. |
|
|
Aug 30, 2010 |
1208 |
| Teriflunomide Significantly Reduced Annualized Relapse Rate and was Well Tolerated in MS Patients. |
|
|
Aug 30, 2010 |
1214 |
| Society of Interventional Radiology Supports Research for New M.S. Treatments. |
|
|
Aug 26, 2010 |
1005 |
| Opexa Reconstitutes Scientific Advisory Board with Industry Leaders. |
|
|
Aug 5, 2010 |
1810 |
| Merck Serono: FDA Grants Priority Review to Cladribine Tablets for the Treatment of Relapsing Forms of MS. |
|
|
Jul 28, 2010 |
1243 |
| EMD Serono, Inc.: FDA Grants Priority Review to Cladribine Tablets for the Treatment of Relapsing Forms of MS. |
|
|
Jul 28, 2010 |
1274 |
| Immune protein for multiple sclerosis could help asthma patients too. |
|
|
Jul 14, 2010 |
302 |
| Merck Serono's Cladribine Tablets for MS Approved in Russia. |
|
|
Jul 12, 2010 |
1384 |
| Epstein-Barr virus and MS: causality or association? |
Ludwin, S.K.; Jacobson, S. |
Clinical report |
Jul 1, 2010 |
3853 |
| Russell Brain's review of MS. |
Murray, T.J. |
Clinical report |
Jul 1, 2010 |
2089 |
| American Academy of Neurology Annual Meeting: Toronto, Canada, 10-17 April 2010. |
Willoughby, Ernest |
Conference notes |
Jul 1, 2010 |
638 |
| Sixty-Two Year Old Chemotherapy Treatment Shows Promising Results on Progressive Multiple Sclerosis Patients. |
|
|
Jun 28, 2010 |
583 |
| Hot, humid weather can be uncomfortable for anyone, but for patients with multiple sclerosis (MS), the heat can cause a recurrence of MS symptoms. |
|
|
Jun 22, 2010 |
162 |
| When a kid has MS. |
Formichelli, Linda |
Cover story |
Jun 22, 2010 |
1495 |
| Getting pediatric MS right. |
Boerner, Heather |
|
Jun 22, 2010 |
875 |
| What pediatric MS may reveal about adult-onset MS. |
|
|
Jun 22, 2010 |
684 |
| A work in progress: the National MS Society arranged to have an independent freelance journalist who lives with MS attend and report on the April 14 Web forum. |
Dale, Alison |
|
Jun 22, 2010 |
991 |
| Promises made promises kept promise: Promise: 2010. |
|
|
Jun 22, 2010 |
868 |
| A list to avoid. |
Nelson, Joyce |
|
Jun 22, 2010 |
381 |
| Cecilia Reyes: the understanding you need. |
Durand, Marcella |
|
Jun 22, 2010 |
459 |
| Learning from traditional Chinese medicine and Ayurveda. |
Bowling, Allen C. |
|
Jun 22, 2010 |
1070 |
| Beat the heat! |
Kraft, George H. |
|
Jun 22, 2010 |
403 |
| Words: typing can be easier. |
Wadsley, Patricia |
|
Jun 22, 2010 |
696 |
| Handheld help. |
Thompson, Chloe |
|
Jun 22, 2010 |
400 |
| The funny page: the trips I've taken, the falls I've seen. |
Martin, Martha Skye |
Viewpoint essay |
Jun 22, 2010 |
739 |
| Untethered: is a suprapubic catheter for you? |
Boerner, Heather |
|
Jun 22, 2010 |
852 |
| Eric Hovde brings investment thinking to the MS research effort. |
King, Martha |
|
Jun 22, 2010 |
430 |
| Cell therapy for MS. |
Bernstein, Sara |
|
Jun 22, 2010 |
1303 |
| Not just a high: scientists test medicinal marijuana against ms, inflammation and cancer. |
Seppa, Nathan |
|
Jun 19, 2010 |
3039 |
| Biogen Idec Announces Enrollment of First Patient in Phase II BG-12 Combination Trial in Multiple Sclerosis. |
|
|
Jun 15, 2010 |
1161 |
| Teriflunomide in Adjunct to Interferon Beta Significantly Improved Outcomes of Multiple Sclerosis Patients. |
|
|
Jun 7, 2010 |
1392 |
| Teriflunomide in Adjunct to Interferon Beta Significantly Improved Outcomes of Multiple Sclerosis Patients. |
|
|
Jun 7, 2010 |
1398 |
| Teriflunomide in Adjunct to Interferon Beta Significantly Improved Outcomes of Multiple Sclerosis Patients. |
|
|
Jun 5, 2010 |
1392 |
| Teriflunomide in Adjunct to Interferon Beta Significantly Improved Outcomes of Multiple Sclerosis Patients. |
|
|
Jun 5, 2010 |
1398 |
| Cognitive impairment in patients with early relapsing-remitting multiple sclerosis/Erken donem relapsing-remitting multipl skleroz hastalarinda bilissel islev bozukluklari. |
Keklikoglu, Hava Donmez; Yoldas, Tahir Kurtulus; Zengin, Ozkan; Solak, Elif Banu; Keskin, Selda |
Clinical report |
Jun 1, 2010 |
2350 |
| Biogen Idec Globally Commemorates Annual World MS Day. |
|
|
May 25, 2010 |
1819 |
| Charity demands action over MS patients' 'lottery' Society hits out at availability of electric treatment. |
|
|
Apr 26, 2010 |
732 |
| Teva Neuroscience Announces New Data Demonstrated Significant Impact of Access to Neutralizing Antibody Testing on MS Treatment Management. |
|
|
Apr 14, 2010 |
1511 |
| Controlling medical costs. |
Sullivan, Gary |
Column |
Mar 22, 2010 |
631 |
| Wise choices in action: The example of acai. |
Bowling, Allen C. |
|
Mar 22, 2010 |
869 |
| VALT reaches out to veterans. |
Durand, Marcella |
|
Mar 22, 2010 |
386 |
| A Comparison of Self-hypnosis versus Progressive Muscle Relaxation in Patients with Multiple Sclerosis and Chronic Pain. |
Hartman, David |
Abstract |
Mar 22, 2010 |
216 |
| Hypnosis for Pain and Neuromuscular Rehabilitation with Multiple Sclerosis: Case Summary, Literature Review, and Analysis of Outcomes. |
Hartman, David |
Abstract |
Mar 22, 2010 |
140 |
| Clinical usefulness of cerebrospinal fluid evaluation. |
Fredrikson, S. |
Report |
Mar 1, 2010 |
2299 |
| Acorda Therapeutics Announces Availability of AMPYRA[TM] (dalfampridine). |
|
|
Mar 1, 2010 |
1064 |
| Copaxone[R] 15-Year Study in Multiple Sclerosis Patients Demonstrates Robust Long-Term Efficacy and Safety. |
|
Clinical report |
Feb 25, 2010 |
1253 |
| New therapy for relapsing multiple sclerosis shows promise. |
|
|
Feb 22, 2010 |
480 |
| New Study Finds Specialized Support Programs Can Increase Treatment Adherence and Persistence, Reduce Relapses for People with Multiple Sclerosis. |
|
|
Feb 8, 2010 |
1356 |
| Acorda Therapeutics Announces Pricing and Patient Assistance Programs for AMPYRA[TM] (dalfampridine). |
|
|
Feb 3, 2010 |
1066 |
| Effect of oral antihistamine on local injection site reactions with self-administered glatiramer acetate. |
Pardo, Gabriel; Boutwell, Christine; Conner, Jill; Denney, Douglas; Oleen-Burkey, MerriKay |
Report |
Feb 1, 2010 |
4373 |
| Oral MS Therapy Results Represent "Shifting Tide". |
|
|
Jan 20, 2010 |
311 |
| Biogen Idec Submits Application in Europe for the Approval of Fampridine-PR Tablets to Improve Walking Ability in People with Multiple Sclerosis. |
|
|
Jan 12, 2010 |
762 |
| Guidelines updated for MRIs in multiple sclerosis. |
Sullivan, Michele G. |
Disease/Disorder overview |
Jan 1, 2010 |
576 |
| Quality of life in patients with multiple sclerosis and urinary disorders: reliability and validity of Turkish-language version of Incontinence Quality of Life Scale. |
Eyigor, Sibel |
Brief article |
Jan 1, 2010 |
89 |
| Quality of life in patients with multiple sclerosis and urinary disorders: reliability and validity of Turkish-language version of Incontinence Quality of Life Scale. |
Eyigor, Sibel; Karapolat, Hale; Akkoc, Yesim; Yesil, Hilal; Ekmekci, Ozgul |
Report |
Jan 1, 2010 |
2776 |
| Seasoned Clinical Development Expert Joins Opexa to Lead Tovaxin[R] Development in Multiple Sclerosis. |
|
|
Dec 2, 2009 |
1260 |
| The impact of pain and other symptoms on quality of life in women with relapsing-remitting multiple sclerosis. |
Newland, Pamela K.; Naismith, Robert T.; Ullione, Margaret |
Report |
Dec 1, 2009 |
4776 |
| Band rocks for MS therapy centre. |
|
|
Nov 23, 2009 |
86 |
| Observational studies: propensity score analysis of non-randomized data. |
Trojano, M.; Pellegrini, F.; Paolicelli, D.; Fuiani, A.; Di Renzo, V. |
Report |
Nov 1, 2009 |
4922 |
| Constantly changing lives: experiences of people with multiple sclerosis. |
Lexell, Eva Mansson; Lund, Maria Larsson; Iwarsson, Susanne |
Report |
Nov 1, 2009 |
7334 |
| Chabad Opens Revamped Multiple Sclerosis Center. |
|
Brief article |
Oct 20, 2009 |
82 |
| Fighting MS. |
|
Brief article |
Oct 1, 2009 |
207 |
| Merck Serono Submits Application for Cladribine Tablets as a Potential Oral Short-Course Multiple Sclerosis Therapy in the United States. |
|
|
Sep 30, 2009 |
1055 |
| Results From Improve Study Show MRI Benefits of Rebif(R) Seen Early in Relapsing-Remitting Multiple Sclerosis Treatment and Sustained Over Time. |
|
|
Sep 11, 2009 |
1293 |
| COPAXONE[R] Significantly Reduced Disease Severity in Long-Term Treated Multiple Sclerosis Patients. |
|
Clinical report |
Sep 10, 2009 |
1425 |
| Opexa Reports Additional Favorable Data with Tovaxin[R] for Multiple Sclerosis. |
|
Clinical report |
Sep 8, 2009 |
1026 |
| Merck Serono Submits Application for Cladribine Tablets as Multiple Sclerosis Therapy in Europe. |
|
|
Jul 23, 2009 |
1125 |
| Only one place on the island offers treatment for MS. |
|
|
Jul 12, 2009 |
329 |
| Montel Williams: taking responsibility for living well. |
Caruso, Donna |
Interview |
Jul 1, 2009 |
2780 |
| Spotlight series: pivotal trials through today's knowledge--adrenocorticotrophic hormone. |
Sibley, W.A. |
Report |
Jul 1, 2009 |
3046 |
| MS Forum workshop: looking ahead--advances in multiple sclerosis in the next decade: Athens, Greece, 22 October 2008. |
Clanet, M.; Ebers, G.C |
Conference news |
Jul 1, 2009 |
1866 |
| BioScrip Commences Patient Enrollment in Teva Neuroscience Therapy Optimization in Multiple Sclerosis (Tops MS) Research Study. |
|
Report |
Jun 30, 2009 |
484 |
| Merck Serono Launches RebiSmart(TM), First Electronic Injection Device for Delivery of Multiple Sclerosis Treatment Rebif(R). |
|
|
Jun 24, 2009 |
1200 |
| Biogen Idec Announces First Patient Enrolled in the Global Phase III Study of PEGylated Interferon Beta-1a for Relapsing Multiple Sclerosis. |
|
|
Jun 22, 2009 |
795 |
| Fast forward: fills a research gap. |
Durand, Marcella |
|
Jun 22, 2009 |
363 |
| MS in the news. |
King, Martha |
Editorial |
Jun 22, 2009 |
301 |
| Conventional medications for anxiety: what to know. |
Durand, Marcella |
|
Jun 22, 2009 |
363 |
| Funding the movement: meet Joyce and Andrew Mandell. |
Butler, Karen E. |
|
Jun 22, 2009 |
928 |
| World MS day: a call to action. |
|
Brief article |
Jun 22, 2009 |
268 |
| Seeing the big picture: a national MS registry. |
|
Brief article |
Jun 22, 2009 |
223 |
| Raising money their way: volunteers create unique events. |
|
|
Jun 22, 2009 |
412 |
| Domestic abuse and MS. |
|
|
Jun 22, 2009 |
398 |
| Going to the dogs. |
Nelson, Joyce |
Brief article |
Jun 22, 2009 |
333 |
| Social networking, offline and on. |
Otrompke, John; Sullivan, Gary |
|
Jun 22, 2009 |
1269 |
| Bringing it home: MS researchers take novel ideas from the lab to clinical trials. |
Bernstein, Sara |
|
Jun 22, 2009 |
1378 |
| Research shows the way to healthy living with MS. |
Richert, John R. |
|
Jun 22, 2009 |
872 |
| Trimming the fat: are lipids contributing to MS? |
|
|
Jun 22, 2009 |
900 |
| Results from small study of stem cell therapy to "reboot" immune system. |
|
Brief article |
Jun 22, 2009 |
145 |
| Pregnancy-induced atypic demyelinating inflammatory disease/Gebelikle tetiklenen atipik inflamatuvar demiyelinizan hastallk. |
Durmus, Hacer; Tuzun, Erdem; Kurtuncu, Murat; Mutlu, Melike; Demir, Gulden Akman; Eraksoy, Mefkure |
Clinical report |
Jun 1, 2009 |
2050 |
| Overlap of multiple sclerosis and antiphospholipid syndrome/ Multipl skleroz ve antifosfolipid sendromu birlikteligi. |
Tekeoglu, Ibrahim; Tombul, Temel; Hiz, Ozcan; Gulcu, Elif; Toprak, Murat |
Case study |
Jun 1, 2009 |
2134 |
| MS patients not being offered necessary treatment. |
|
|
May 28, 2009 |
724 |
| Biogen Idec Joins with the Global MS Community to Mark World MS Day. |
|
|
May 27, 2009 |
1639 |
| First Ten-Year Follow-Up Shows That Treatment with AVONEX[R] Leads to Long-Term Benefits in Early Multiple Sclerosis Patients. |
|
|
Apr 30, 2009 |
716 |
| Long-Term Study with COPAXONE[R] Indicated Protective Effect on Brain Tissue in Multiple Sclerosis Patients. |
|
Clinical report |
Apr 28, 2009 |
1193 |
| Opexa Publication of Tovaxin[R] Clinical Data in Journal of Clinical Immunology. |
|
Clinical report |
Apr 24, 2009 |
1208 |
| Stem cells from fat tissue offer MS treatment hope. |
|
|
Apr 24, 2009 |
303 |
| Genetic 'brakes' discovery offers hope to multiple sclerosis, cancer patients. |
|
|
Apr 20, 2009 |
407 |
| Genzyme and Bayer HealthCare Enter New Strategic Agreement. |
|
|
Mar 31, 2009 |
2601 |
| Easing into the right seat. |
Blose, Chris |
|
Mar 22, 2009 |
959 |
| Who can help the helpers? |
Herron, Greta; Wadsley, Patricia |
|
Mar 22, 2009 |
485 |
| The many pluses of pets. |
Durand, Marcella |
|
Mar 22, 2009 |
1275 |
| Let's play. |
Chamberlayne, Nancy |
|
Mar 22, 2009 |
818 |
| Fitness and low vision? Yes! |
Cohen, Joyce Render; Katz, Evelyn Render |
|
Mar 22, 2009 |
677 |
| Updated MS Atlas published. |
|
Brief article |
Mar 22, 2009 |
169 |
| MS repair "dream teams" making progress. |
Bernstein, Sara |
|
Mar 22, 2009 |
1381 |
| What's new? Researchers venture down novel pathways in MS. |
|
Report |
Mar 22, 2009 |
832 |
| A review of pharmacologic and therapeutic interventions for persons with depression and multiple sclerosis. |
Feisthamel, Kevin P. |
|
Mar 22, 2009 |
2974 |
| Physical exercise and MS--recommendations. |
Dalgas, U.; Ingemann-Hansen, T.; Stenager, E. |
Report |
Mar 1, 2009 |
4800 |
| The World Congress on Treatment and Research in Multiple Sclerosis (joint meeting of ECTRIMS, ACTRIMS, LACTRIMS): Montreal, Canada, 17-20 September 2008. |
Clanet, M. |
Conference news |
Mar 1, 2009 |
755 |
| BIOMS REPORTS ON PHASE II DIRUCOTIDE FOR MULTIPLE SCLEROSIS. |
|
|
Mar 1, 2009 |
973 |
| Concomitance of ankylosing spondylitis and multiple sclerosis: a case report/ Ankilozan spondilit ve multipl sklerozun beraber goruldugu bir olgu. |
Tastekin, Nurettin; Uzunca, Kaan; Celik, Yahya; Kurtoglu, Dilek |
Case study |
Mar 1, 2009 |
966 |
| The effects of a twelve-week home walking program on cardiovascular parameters and fatigue perception of individuals with multiple sclerosis: a pilot study. |
Costello, Ellen; Raivel, Kerry; Wilson, Raina |
Report |
Mar 1, 2009 |
5981 |
| Oral Laquinimod for Multiple Sclerosis Granted Fast Track Status by FDA. |
|
|
Feb 12, 2009 |
1383 |
| MS Patients Treated with TYSABRI[R] Remain Free of Disease Activity for Two Years, According to Data Published in the Lancet Neurology. |
|
|
Feb 9, 2009 |
1463 |
| COPAXONE[R] is Approved for Treatment of Patients with a First Clinical Event Suggestive of Multiple Sclerosis. |
|
|
Feb 4, 2009 |
1284 |
| Diet, disability, and Dorothy (the food fascist). |
Levinson, Jerry |
Column |
Feb 1, 2009 |
857 |
| Injecting own bone marrow stem cells in early-stage MS patients may reverse the disease. |
|
|
Feb 1, 2009 |
596 |
| Opexa Provides Update on Various Corporate Developments. |
|
|
Jan 20, 2009 |
1632 |
| There's always hope. |
Davis, Nancy |
|
Jan 1, 2009 |
1660 |
| Promoting excellence in long-term care. |
Durand, Marcella |
Report |
Dec 22, 2008 |
225 |
| All that is green is not always good. |
Bowling, Allen C. |
Report |
Dec 22, 2008 |
862 |
| Putting the boogeyman to bed: asking the hard questions. |
Boerner, Heather |
Cover story |
Dec 22, 2008 |
1063 |
| What's ahead for you? Planning to plan. |
Boerner, Heather |
Cover story |
Dec 22, 2008 |
3740 |
| What will genes tell us? |
Sullivan, Gary |
Cover story |
Dec 22, 2008 |
625 |
| What's in store for me? Medical prognosis now and to come. |
Sullivan, Gary |
Cover story |
Dec 22, 2008 |
485 |
| Decisions, decisions, decisions. |
King, Martha |
Editorial |
Dec 22, 2008 |
315 |
|
